Moonwalk Team

Stephen Djedjos, M.D. is Senior Vice President and Head of Clinical Development at Moonwalk. Stephen has over 20 years of clinical and drug development experience across all stages of drug development utilizing large and small molecules as well as cellular and gene therapies. Originally from Louisiana, Stephen completed his medical school and residency in Internal Medicine and Pediatrics at LSU before completing a fellowship in Pediatric Endocrinology at Johns Hopkins Hospital. After several years of clinical practice, Stephen transitioned into industry at Amgen and contributed to the filing and approval of Repatha®. He subsequently led clinical development for multiple programs at Gilead and Sana before spending time most recently at Kailera developing novel incretin therapies for patients living with obesity. Stephen is passionate about bringing new therapies to patients living with serious medical conditions.